5-Amino Levulinic Acid Effective Against SARS-CoV-2

A study revealed that 5-amino levulinic acid (5-ALA) inhibits SARS-CoV-2 in vitro. As 5-ALA is safe to use as it is a natural amino acid found in plants, animals, fungi and bacteria. When eight molecules of 5-ALA combine it forms protoporphyrin IX which generates heme when combined with a ferrous ion. Recent studies have shown antiviral properties of 5-ALA against dengue and Zika virus. The potency of 5-ALA against SARS-CoV-2 was tested in VeroE6 where the virus was propagated.

The study revealed that when the VeroE6 cells were treated with 5-ALA for 72 hours before infection, it prevented SARS-CoV-2 infection. A shorter pre-treatment of 48 hours did not prevent the infection. Adding sodium ferrous citrate along with 5-ALA also prevented the infection. The researchers suggested that a G-quadruplex structure could be a potential target of the antivirals and compounds binding to it could inhibit SARS-CoV-2 infection. G4 is a tetrahelical structure formed by guanine-rich regions of DNA or RNA and is also found in coronaviruses.

SARS-CoV-2 genome has G4 structures with a SARS unique macrodomain like motif in its non-structural protein-3 which could be a potential target for antiviral drugs. Heme, a 5-ALA metabolite is known to complex with G4 structures. It could target the viral protein and inhibit SARS-CoV-2. 

To know more about origin, virology of COVID-19, Click here

To know more about emerging themes in COVID-19, Click here

To know more about how WhiteCoats can help you in your professional advancement, visit www.whitecoats.com

Want to set up an online consultation for your practice, Click here

Ref link: https://www.biorxiv.org/content/10.1101/2020.10.28.355305v1